[1] Takeya H, Tanaka Y, Suzuki K. Thrombosis and apoptosis[J]. Rinsho Byori, 1997, 45:614-620.
[2] Tedgui A, Mallat Z. Acute coronary thrombosis[J]. Rev Prat,2003, 53(6):602-606.
[3] Greeno EW, Bach RR, Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant acitivity[J]. Lab Invest, 1996, 75:281-289.
[4] Wang J, Weiss I, Svoboda K, et al. Thrombogenic role of cells undergoing apoptosis[J]. Br J Haematol, 2001, 115(2):382-391.
[5] Tedgui A, Mallat Z. Apoptosis as a determinant of atherothrombosis[J]. Thromb Haemost, 2001, 86:420-426.
[6] Ananyeva NM, Kouiavskaia DV, Shima M, et al. Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque[J]. Blood, 2002, 99(12):4475-4485.
[7] Bombeli T, Karsan A, Tait JF, et al. Apoptotic vascular endothelial cells become procoagulant[J]. Blood, 1997, 89:2429-2442.
[8] Mallat Z, Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease[J]. Circ Res, 2001, 88(10):998-1003.
[9] Uzan A. Thrombosis and ischemia:experimental data[J].Arch Mal Coeur Vaiss, 2002, 95(7):31-35.
[10] Crumpton MJ, Dedman JR. Protein terminology tangle[J].Nature, 1990, 345:212.
[11] Peng L, Jiang H, Bradely C. Detection of B lymphoma cells undergoing apoptosis by Annexin-V assay[J]. Chin Med Sci J, 2002,17(1):17-21.
[12] Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death[J]. Proc Natl Acad Sci USA, 1998,95:6349-6354.
[13] Blankenberg FG, Katsikis PD, Tait JF, et al. Imaging of apoptosis (programmed cell death) with 99m-Tc annexin V[J]. J Nucl Med, 1999, 40:184-191.
[14] Vriens PW, Blankenberg FG, Stoot JH, et al. The use of technetium Tc annexin V for in vivo imaging of apoptosis during cardiac allograft rejection[J]. J Thorac Cardiovasc Surg, 1998, 116:844-853.
[15] Belhocine T, Steinmetz N, Hustinx R, et al. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis[J]. Clin Cancer Res, 2002,8(9):2766-2774.
[16] Ohtsuki K, Akashi K, Aoka Y, et al. Technetium-99m HYNIC-annexin V:a potential radiopharmacentical for the in-vivo detection of apoptosis[J]. Eur J Nucl Med, 1999, 26:1251-1258.
[17] Blankenberg FG, Ohsuki K, Strauss HW. Dying a thousand deaths, Radionuclide imaging of apoptosis[J]. J Nucl Med,1999, 43:170-176.
[18] Stratton JR, Dewhurst TA, Kasina S, et al. Selective uptake of radiolabeled annexin V on acute porcine left artial thrombi[J]. Circulation, 1995, 92:3113-3121.
[19] Schellenberger EA, Bogdanov A Jr, Hogemann D, et al.Annexin V-CLIO:a nanoparticle for detecting apoptosis by MRI[J]. Mol Imaging, 2002, 1(2):102-107.
[20] Glaser M, Collingridge DR, Aboagye EO, et al. Iodine-124labelled annexin-V as a potential radiotracer to study apoptosis using positron emission tomography[J]. Appl Radiat Isot, 2003, 58(1):55-62.